株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオプリンティング:技術と世界市場

Bioprinting: Technologies and Global Markets

発行 BCC Research 商品コード 379859
出版日 ページ情報 英文 99 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.05円で換算しております。
Back to Top
バイオプリンティング:技術と世界市場 Bioprinting: Technologies and Global Markets
出版日: 2016年10月27日 ページ情報: 英文 99 Pages
概要

世界のバイオプリンティング市場規模は、2016年から2021年にかけて43.9%のCAGR (複合年間成長率) で推移し、2016年の2億9,500万米ドルから、2021年までに18億米ドルまで拡大すると予測されています。

当レポートでは、世界のバイオプリンティング市場について調査分析し、概要、市場動向の分析、最新技術の分析、技術・用途・エンドユーザー別の分析、市場ダイナミクスの評価、主要企業のプロファイル、および特許分析などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 概要

  • 調査範囲
  • バイオプリンティング市場
  • 成長促進因子
  • バイオプリンティングの製品ライフサイクル状況
  • バイオプリンティング産業

第4章 技術

  • イントロダクション
  • 3D細胞培養プラットフォーム
  • バイオプリンティング対応プラットフォーム
  • バイオプリンティング計器技術
  • バイオインク技術
  • バイオリアクター
  • ソフトウェア
  • 臓器オン・チップ (ORGAN-ON-CHIP)
  • 臓器とオルガノイド

第5章 バイオプリンティング用途

  • イントロダクション
  • 創薬・開発における組織モデル
  • 化粧品における毒性試験
  • 再生医療におけるヒト組織工学
  • バイオプリンテッド製品の米国における規制状況
  • 臓器移植

第6章 バイオプリンティング産業

  • イントロダクション
  • 3D細胞培養産業
  • バイオインク産業
  • バイオプリント計器産業
  • 皮膚代用物産業
  • 臓器/細胞オン・チップ産業
  • 買収・戦略的アライアンス

第7章 バイオプリンティング市場

  • 市場成長の促進因子
  • バイオプリンティング市場
  • 計器市場
  • 試薬市場
  • 体外試験市場
  • 臨床市場
  • 地域市場

第8章 バイオプリンティング特許

  • イントロダクション
  • 特許検索
  • バイオプリンテッド臓器の特許
  • バイオプリンティング特許のサマリー

第9章 企業プロファイル

  • 3D BIO CORP.
  • 3D BIOPRINTING SOLUTIONS
  • 3D BIOTEK LLC
  • 3DYNAMIC SYSTEMS LTD.
  • ADVANCED POLYMER TECHNOLOGY AB
  • ADVANCED SOLUTIONS INC.
  • ANYPRINT
  • ASPECT BIOSYSTEMS LTD.
  • AUTODESK INC.
  • AXOSIM TECHNOLOGIES
  • BIO3-D TECHNOLOGIES
  • BIOBOTS
  • BIOCURIOUS
  • BRAINGINEERING TECHNOLOGIES S.A.R.L.
  • CELENYS
  • COLLPLANT LTD.
  • CYFUSE BIOMEDICAL K.K.
  • DIGILAB INC.
  • EMULATE INC.
  • ENVISIONTEC GMBH
  • GESELLSCHAFT FUR SILIZIUMMIKROSYSTEME MBH
  • HEMOSHEAR THERAPEUTICS LLC
  • INSPHERO AG
  • MATERIALISE NV
  • MICROFAB TECHNOLOGIES
  • N3-D BIOSCIENCES
  • NEXT21 K.K.
  • NSCRYPT INC.
  • ORGANOVO HOLDINGS INC.
  • OUROBOTICS
  • OXSYBIO
  • PANDORUM TECHNOLOGIES PVT. LTD.
  • POIETIS
  • QINGDAO UNIQUE PRODUCTS DEVELOP CO. LTD.
  • REGEMAT 3-D S.L.
  • REGENHU LTD
  • ROKIT
  • ROOSTERBIO INC.
  • TISSUSE GMBH
  • SERAPH ROBOTICS INC.
  • SICHUAN REVOTEK CO. LTD.
  • STEMONIX INC.
  • STRATASYS LTD.
  • SUNP BIOTECH LLC
  • TARA BIOSYSTEMS INC.
  • TEVIDO BIODEVICES LLC

図表

目次
Product Code: BIO148A

REPORT HIGHLIGHTS

The global market for bioprinting reached $263.8 million in 2015. The market should reach $295 million in 2016 and $1.8 billion by 2021, growing at a compound annual growth rate (CAGR) of 43.9% from 2016 to 2021.

This report provides:

  • An overview of the global markets bioprinting.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Analysis of the latest techniques used to create cell patterns within a confined space.
  • Breakdowns of the market by technology, application, and end-user.
  • Evaluation of the market's dynamics, specifically growth drivers, opportunities, and restraints.
  • Profiles of major players in the field.

SCOPE AND FORMAT OF REPORT

The scope of the report includes bioprinting technologies, applications, industries, markets, patents and companies. The market estimates and forecasts for bioprinting products and services are given for the years 2015, 2016 and 2021.

This report reviews the main bioprinting and bioink platforms, and explains why printing living cells is technically challenging, yet can be extremely rewarding if the technology can be mastered. The report covers the main applications for bioprinting including in vitro models and in vivo regenerative medicine applications.

Industry market driving forces are discussed, including key trends favoring adoption of bioprinting tools.

The report covers the bioprinting markets by workflow, including bioprinting reagents, instruments, software, clinical procedures, and tissue formats such as tissue-on-chip.

The report analyzes the markets for the main bioprinting end-use applications, including research, drug discovery and development, cosmetics, and clinical.

Bioprinting clinical markets discussed include cardiovascular, craniofacial repair, orthopedics, and wound care. The wound care market is analyzed by individual segments, including acute wounds, chronic wounds, and hernia repair.

The specific geographic markets include North America, Europe, Asia/Pacific and the rest of the world.

Market data covers the years 2015, 2016 and 2021.

The report analyzes specific bioprinting-related industries, including 3-D cell culture; bioinks; bioprinting instruments; skin substitutes; and organ/tissue-on-chip.

More than 45 companies in the bioprinting industry are profiled in this report.

BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2014 through mid-2016, including key alliance trends.

ANALYST'S CREDENTIALS

Mr. John Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with a nanotechnology/separations company. Mr. Bergin holds a BS degree in Chemistry, an MS degree in Biotechnology and a Master of Business Administration.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • INTENDED AUDIENCE
  • SCOPE AND FORMAT OF REPORT
  • METHODOLOGY
  • INFORMATION SOURCES
  • RELATED BCC RESEARCH REPORTS
  • ANALYST'S CREDENTIALS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE GLOBAL BIOPRINTING MARKET BY APPLICATION, THROUGH 2021 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL BIOPRINTING MARKET BY APPLICATION, 2015-2021 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • REPORT SCOPE
    • TABLE 1: 3-D BIOPRINTING SCOPE
  • BIOPRINTING MARKET
    • TABLE 2: GLOBAL BIOPRINTING MARKET BY END USER INDUSTRY, THROUGH 2021 ($ MILLIONS)
  • GROWTH DRIVING FORCES
    • TABLE 3: BIOPRINTING INDUSTRY KEY GROWTH DRIVING FORCES
  • BIOPRINTING PRODUCT LIFE CYCLE STATUS
    • TABLE 4: LIFE CYCLE OF BIOPRINTING PRODUCTS
  • BIOPRINTING INDUSTRY
    • TABLE 5 CHARACTERISTICS OF BIOPRINTING INDUSTRY SEGMENTS

CHAPTER 4 - TECHNOLOGIES

  • INTRODUCTION
    • TABLE 6: COMPARISON OF BIOPRINTING WITH 3-D PRINTING
  • 3-D CELL CULTURE PLATFORMS
    • TABLE 7: 3-D CELL CULTURE PLATFORMS
  • BIOPRINTING ENABLING PLATFORMS
    • TABLE 8: BIOPRINTING EMERGING PLATFORMS
  • BIOPRINTING INSTRUMENT TECHNOLOGIES
    • TABLE 9: BIOPRINTING INSTRUMENT TECHNOLOGIES
    • TABLE 10: MAINTAINING CELL VIABILITY DURING PRINTING
  • BIOINK TECHNOLOGIES
    • TABLE 11: BIOINK COMPONENTS
    • TABLE 12: BIOINK TYPES
    • TABLE 13: MATRIX BIOINK HYDROGEL CLASSES
    • TABLE 14: MATRIX BIOINK SELECTION CRITERIA
  • BIOREACTORS
  • SOFTWARE
  • ORGAN-ON-CHIP
  • ORGANS AND ORGANOIDS
    • ORGANOIDS
    • ORGANS
      • TABLE 15: PUBLIC POLICY ISSUES RELATING TO BIOPRINTED ORGANS
    • TECHNOLOGY CHALLENGES FOR PRINTING ORGANS
      • TABLE 16: BIOPRINTING OF ORGANS: TECHNOLOGY CHALLENGES

CHAPTER 5 - BIOPRINTING APPLICATIONS

  • INTRODUCTION
    • TABLE 17: BIOPRINTING APPLICATIONS
  • TISSUE MODELS IN DRUG DISCOVERY AND DEVELOPMENT
    • TABLE 18: COMPARISON BETWEEN 2-D AND 3-D CELL CULTURE MODELS
    • TABLE 19: BENEFITS OF 3-D CELL CULTURE MODELS IN DRUG DISCOVERY AND DEVELOPMENT
    • TABLE 20: BIOPRINTING APPLICATION ACROSS THE DRUG DISCOVERY AND DEVELOPMENT VALUE CHAIN
  • TOXICOLOGY TESTING IN COSMETICS
    • TABLE 21: IN VITRO TESTING IN COSMETICS
    • TABLE 22: BIOPRINTING INDUSTRY ALLIANCES IN COSMETICS, 2015
  • TISSUE ENGINEERING IN REGENERATIVE MEDICINE
    • TABLE 23: PRINTED TISSUE AND ORGANS: COMMERCIALIZATION TIMEFRAME
    • TABLE 24: TISSUE/ORGAN COMPLEXITY
  • U.S. REGULATORY STATUS OF BIOPRINTED PRODUCTS
    • TABLE 25: U.S. REGULATORY CONSIDERATIONS
  • ORGAN TRANSPLANTS
    • TABLE 26: UNITED STATES ORGAN TRANSPLANTS, JAN. TO JUNE 2016

CHAPTER 6 - BIOPRINTING INDUSTRY

  • INTRODUCTION
  • 3-D CELL CULTURE INDUSTRY
    • TABLE 27: 3-D CELL CULTURE INDUSTRY
  • BIOINK INDUSTRY
    • TABLE 28: SELECTED BIOINK COMPANIES
  • BIOPRINT INSTRUMENT INDUSTRY
    • TABLE 29: BIOPRINTING INSTRUMENT INDUSTRY
  • SKIN SUBSTITUTES INDUSTRY
    • TABLE 30: SUMMARY OF SKIN SUBSTITUTE PRODUCTS AND MARKET FOCUS
  • ORGAN/TISSUE-ON-CHIP INDUSTRY
    • TABLE 31: ORGAN-ON-CHIP INDUSTRY
  • ACQUISITIONS AND STRATEGIC ALLIANCES
    • TABLE 32: BIOPRINTING INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES, JAN. 2014 TO JUNE 2016

CHAPTER 7 - BIOPRINTING MARKETS

  • MARKET GROWTH DRIVING FORCES
    • TABLE 33: BIOPRINTING INDUSTRY KEY GROWTH DRIVING FORCES
  • BIOPRINTING MARKET
    • TABLE 34: GLOBAL BIOPRINTING MARKET BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 35: GLOBAL BIOPRINTING MARKET BY END USER INDUSTRY, THROUGH 2021 ($ MILLIONS)
  • INSTRUMENT MARKET
    • TABLE 36: GLOBAL BIOPRINT INSTRUMENTS MARKET BY CLASS, THROUGH 2021 ($ MILLIONS)
    • TABLE 37: GLOBAL BIOPRINT INSTRUMENTS MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
  • REAGENTS MARKET
    • TABLE 38: GLOBAL BIOPRINT REAGENTS MARKET BY TYPE, THROUGH 2021 ($ MILLIONS)
  • IN VITRO TEST MARKETS
    • TABLE 39: GLOBAL IN VITRO TESTING MARKET BY INDUSTRY, THROUGH 2021 ($ MILLIONS)
    • TABLE 40: GLOBAL IN VITRO RESEARCH TESTING MARKET BY FIELD, THROUGH 2021 ($ MILLIONS)
  • CLINICAL MARKETS
    • TABLE 41: GLOBAL BIOPRINT CLINICAL MARKET BY APPLICATION, THROUGH 2021 ($ MILLIONS)
    • TABLE 42: REGULATION OF HUMAN TISSUE AND CELL-BASED CLINICAL PRODUCTS
    • TABLE 43: LOBAL BIOPRINT CLINICAL WOUND CARE MARKET BY APPLICATION, THROUGH 2021 ($ MILLIONS)
    • TABLE 44: BENEFITS OF BIOPRINTED SKIN SUBSTITUTES
  • GEOGRAPHIC MARKETS
    • TABLE 45: GLOBAL BIOPRINT MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 46: GLOBAL BIOPRINTING IN VITRO MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 47: GLOBAL BIOPRINTING CLINICAL MARKET BY REGION, THROUGH 2021 ($ MILLIONS)

CHAPTER 8 - BIOPRINTING PATENTS

  • INTRODUCTION
  • PATENT SEARCHES
    • TABLE 48: BIOPRINTING PATENT LANDSCAPE BY REGION, 2005-2015
    • TABLE 49: BIOINK PATENT LANDSCAPE BY REGION, 2005-2015 (NO. OF PATENTS)
    • TABLE 50: SCAFFOLDS PATENT LANDSCAPE BY REGION, 2005-2015 (NO. OF PATENTS)
    • TABLE 51: 3-D TISSUE MODEL PATENT LANDSCAPE BY REGION, 2005-2015 (NO. OF PATENTS)
    • TABLE 52: ORGAN-ON-CHIP PATENT LANDSCAPE BY REGION, 2005-2015 (NO. OF PATENTS)
  • PATENTING OF BIOPRINTED ORGANS
  • BIOPRINTING PATENTS SUMMARY

CHAPTER 9 - COMPANY PROFILES

  • 3D BIO CORP.
  • 3D BIOPRINTING SOLUTIONS
  • 3D BIOTEK LLC
  • 3DYNAMIC SYSTEMS LTD.
  • ADVANCED POLYMER TECHNOLOGY AB
  • ADVANCED SOLUTIONS INC.
  • ANYPRINT
  • ASPECT BIOSYSTEMS LTD.
  • AUTODESK INC.
  • AXOSIM TECHNOLOGIES
  • BIO3-D TECHNOLOGIES
  • BIOBOTS
  • BIOCURIOUS
  • BRAINGINEERING TECHNOLOGIES S.A.R.L.
  • CELENYS
  • COLLPLANT LTD.
  • CYFUSE BIOMEDICAL K.K.
  • DIGILAB INC.
  • EMULATE INC.
  • ENVISIONTEC GMBH
  • GESELLSCHAFT FUR SILIZIUMMIKROSYSTEME MBH
  • HEMOSHEAR THERAPEUTICS LLC
  • INSPHERO AG
  • MATERIALISE NV
  • MICROFAB TECHNOLOGIES
  • N3-D BIOSCIENCES
  • NEXT21 K.K.
  • NSCRYPT INC.
  • ORGANOVO HOLDINGS INC.
  • OUROBOTICS
  • OXSYBIO
  • PANDORUM TECHNOLOGIES PVT. LTD.
  • POIETIS
  • QINGDAO UNIQUE PRODUCTS DEVELOP CO. LTD.
  • REGEMAT 3-D S.L.
  • REGENHU LTD
  • ROKIT
  • ROOSTERBIO INC.
  • TISSUSE GMBH
  • SERAPH ROBOTICS INC.
  • SICHUAN REVOTEK CO. LTD.
  • STEMONIX INC.
  • STRATASYS LTD.
  • SUNP BIOTECH LLC
  • TARA BIOSYSTEMS INC.
  • TEVIDO BIODEVICES LLC

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL BIOPRINTING MARKET BY APPLICATION, THROUGH 2021 ($ MILLIONS)
    • TABLE 1: 3-D BIOPRINTING SCOPE
    • TABLE 2: GLOBAL BIOPRINTING MARKET BY END USER INDUSTRY, THROUGH 2021 ($ MILLIONS)
    • TABLE 3: BIOPRINTING INDUSTRY KEY GROWTH DRIVING FORCES
    • TABLE 4: LIFE CYCLE OF BIOPRINTING PRODUCTS
    • TABLE 5: CHARACTERISTICS OF BIOPRINTING INDUSTRY SEGMENTS
    • TABLE 6: COMPARISON OF BIOPRINTING WITH 3-D PRINTING
    • TABLE 7: 3-D CELL CULTURE PLATFORMS
    • TABLE 8: BIOPRINTING EMERGING PLATFORMS
    • TABLE 9: BIOPRINTING INSTRUMENT TECHNOLOGIES
    • TABLE 10: MAINTAINING CELL VIABILITY DURING PRINTING
    • TABLE 11: BIOINK COMPONENTS
    • TABLE 12: BIOINK TYPES
    • TABLE 13: MATRIX BIOINK HYDROGEL CLASSES
    • TABLE 14: MATRIX BIOINK SELECTION CRITERIA
    • TABLE 15: PUBLIC POLICY ISSUES RELATING TO BIOPRINTED ORGANS
    • TABLE 16: BIOPRINTING OF ORGANS: TECHNOLOGY CHALLENGES
    • TABLE 17: BIOPRINTING APPLICATIONS
    • TABLE 18: COMPARISON BETWEEN 2-D AND 3-D CELL CULTURE MODELS
    • TABLE 19: BENEFITS OF 3-D CELL CULTURE MODELS IN DRUG DISCOVERY AND DEVELOPMENT
    • TABLE 20: BIOPRINTING APPLICATION ACROSS THE DRUG DISCOVERY AND DEVELOPMENT VALUE CHAIN
    • TABLE 21: IN VITRO TESTING IN COSMETICS
    • TABLE 22: BIOPRINTING INDUSTRY ALLIANCES IN COSMETICS, 2015
    • TABLE 23: PRINTED TISSUE AND ORGANS: COMMERCIALIZATION TIMEFRAME
    • TABLE 24: TISSUE/ORGAN COMPLEXITY
    • TABLE 25: U.S. REGULATORY CONSIDERATIONS
    • TABLE 26: UNITED STATES ORGAN TRANSPLANTS, JAN. TO JUNE 2016
    • TABLE 27: 3-D CELL CULTURE INDUSTRY
    • TABLE 28: SELECTED BIOINK COMPANIES
    • TABLE 29: BIOPRINTING INSTRUMENT INDUSTRY
    • TABLE 30: SUMMARY OF SKIN SUBSTITUTE PRODUCTS AND MARKET FOCUS
    • TABLE 31: ORGAN-ON-CHIP INDUSTRY
    • TABLE 32: BIOPRINTING INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES, JAN. 2014 TO JUNE 2016
    • TABLE 33: BIOPRINTING INDUSTRY KEY GROWTH DRIVING FORCES
    • TABLE 34: GLOBAL BIOPRINTING MARKET BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 35: GLOBAL BIOPRINTING MARKET BY END USER INDUSTRY, THROUGH 2021 ($ MILLIONS)
    • TABLE 36: GLOBAL BIOPRINT INSTRUMENTS MARKET BY CLASS, THROUGH 2021 ($ MILLIONS)
    • TABLE 37: GLOBAL BIOPRINT INSTRUMENTS MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
    • TABLE 38: GLOBAL BIOPRINT REAGENTS MARKET BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 39: GLOBAL IN VITRO TESTING MARKET BY INDUSTRY, THROUGH 2021 ($ MILLIONS)
    • TABLE 40: GLOBAL IN VITRO RESEARCH TESTING MARKET BY FIELD, THROUGH 2021 ($ MILLIONS)
    • TABLE 41: GLOBAL BIOPRINT CLINICAL MARKET BY APPLICATION, THROUGH 2021 ($ MILLIONS)
    • TABLE 42: REGULATION OF HUMAN TISSUE AND CELL-BASED CLINICAL PRODUCTS
    • TABLE 43: LOBAL BIOPRINT CLINICAL WOUND CARE MARKET BY APPLICATION, THROUGH 2021 ($ MILLIONS)
    • TABLE 44: BENEFITS OF BIOPRINTED SKIN SUBSTITUTES
    • TABLE 45: GLOBAL BIOPRINT MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 46: GLOBAL BIOPRINTING IN VITRO MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 47: GLOBAL BIOPRINTING CLINICAL MARKET BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 48: BIOPRINTING PATENT LANDSCAPE BY REGION, 2005-2015
    • TABLE 49: BIOINK PATENT LANDSCAPE BY REGION, 2005-2015 (NO. OF PATENTS)
    • TABLE 50: SCAFFOLDS PATENT LANDSCAPE BY REGION, 2005-2015 (NO. OF PATENTS)
    • TABLE 51: 3-D TISSUE MODEL PATENT LANDSCAPE BY REGION, 2005-2015 (NO. OF PATENTS)
    • TABLE 52: ORGAN-ON-CHIP PATENT LANDSCAPE BY REGION, 2005-2015 (NO. OF PATENTS)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL BIOPRINTING MARKET BY APPLICATION, 2015-2021 ($ MILLIONS)
Back to Top